Trulieve Cannabis Corp Trading Halt and Resumption

On August 1, 2025, Trulieve Cannabis Corp experienced a temporary trading halt and subsequent resumption on the Canadian Securities Exchange (CSE). The trading halt was initiated at 11:30:35 AM ET due to a single-stock circuit breaker, a mechanism designed to ensure a fair and orderly market. The halt lasted for approximately five minutes, with trading resuming at 11:35:35 AM ET.

Trulieve Cannabis Corp, a health care holding company based in Quincy, operates in the United States within the health care sector, specifically in the pharmaceuticals industry. The company is involved in the cultivation, possession, sale, and distribution of medical cannabis products aimed at alleviating symptoms associated with serious medical conditions such as cancer.

As of July 30, 2025, Trulieve Cannabis Corp’s close price was $4.35, with a 52-week high of $13.78 recorded on October 23, 2024, and a 52-week low of $3.02 on April 6, 2025. The company’s market capitalization stands at approximately $729.84 million USD.

The trading halt and resumption were overseen by the Canadian Investment Regulatory Organization (CIRO), the national self-regulatory organization responsible for overseeing investment dealers and trading activities on debt and equity marketplaces in Canada. CIRO’s role includes the authority to impose temporary suspensions of trading to maintain market integrity.

This event highlights the regulatory mechanisms in place to manage market volatility and ensure transparency and fairness in trading activities. Trulieve Cannabis Corp continues to be traded on the Other-OTC stock exchange, with further details available on their website at www.trulieve.com .